close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Hillstream BioPharma

News headline image
Hillstream BioPharma Provides Business Review with Key Pipeline Updates
From Hillstream BioPharma
Via AccessWire
Tickers HILS
News headline image
SAVE THE DATES: Hillstream BioPharma Announces R&D Day on February 24, 2022 and Business Review on Monday February 14, 2022
From Hillstream BioPharma
Via AccessWire
Tickers HILS
News headline image
Hillstream BioPharma Announces Acceptance of Abstract at AACR 2022 Annual Meeting Highlighting HSB-510, a Novel Quatramer-based, First-in-Class Dual Inhibitor of HDAC6 and PI3K-delta Downregulating c-myc Expression
From Hillstream BioPharma
Via AccessWire
Tickers HILS
News headline image
Hillstream BioPharma and University of Massachusetts Chan Medical School Announce Research Collaboration using CRISPR and Computational Approaches to Advance The Hillstream Ferroptomic Atlas
From Hillstream BioPharma
Via AccessWire
Tickers HILS
News headline image
Hillstream BioPharma Announces Closing of Initial Public Offering
From Hillstream BioPharma
Via AccessWire
Tickers HILS
News headline image
Hillstream BioPharma Announces Pricing of Initial Public Offering
From Hillstream BioPharma
Via AccessWire
Tickers HILS
News headline image
Hillstream BioPharma and Minotaur Therapeutics Sign Term Sheet to Advance Next-Generation Targeted Knob Biologics for Undruggable Targets
From Hillstream BioPharma
Via AccessWire
Topics Artificial Intelligence
News headline image
Hillstream BioPharma Expands the Scientific Advisory Board with the Addition of Leading Innovator in the Study of Ferroptosis and Cancer, Scott Dixon, Ph.D.
From Hillstream BioPharma
Via AccessWire
Topics Artificial Intelligence
News headline image
Hillstream BioPharma Announces Abstract at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Highlighting HSB-1216’s Effect in Triple Negative Breast Cancer (TNBC)
From Hillstream BioPharma
Via AccessWire
Topics Artificial Intelligence
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today